MariMed Expands to Maryland with Opening of Cannabis Cultivation Facility in Hagerstown

MariMed client Kind Therapeutics USA LLC (Kind) has successfully passed the Maryland Cannabis Commission compliance inspection of its newly renovated facility designed and developed by MariMed and has commenced cultivation in Hagerstown Maryland at the site of the former Statton Furniture Company. MariMed acquired the 180,000 sq. ft. property, which had been vacant for a decade, and renovated it into a secure, state of the art cannabis cultivation and production facility.  MariMed has leased the facility to Kind Therapeutics, which is expected to employ up to 100 staff and have capacity to produce over two tons of high quality organic cannabis medicine.

Utilizing MariMed’s proven practices and procedures, Kind’s team has successfully begun cultivation of its first cannabis crop. Kind expects to distribute and sell cannabis medicine and products from its first harvest throughout Maryland in the first quarter of 2018.

“Kind Therapeutics’ cultivation team has quickly learned our MariMed processes that have been proven effective in facilities we developed and manage in multiple states,” stated Tim Shaw, MariMed COO.  “We’re thrilled to be partnering to bring economic development and skilled jobs to the area while doing what MariMed does best: providing the management services and branded formulations that will help Kind Therapeutics excel at cultivation, production and distribution of safe, effective, precision-dosed medical cannabis for certified patients’ relief.”

“MariMed has been a true partner in providing expertise and best practices to navigate the complex regulatory requirements,” stated Kind Therapeutics CEO Dr. Susan Zimmerman.   “They took us smoothly from license applicant to completion of a state of the art facility that will create some of the highest quality products in the state.”

Kind’s relationship with MariMed is an example of using MariMed’s full range of managed services from seed-to-sale.   The Hagerstown cultivation and production facility is the latest state-of-the-art, regulatory-compliant facility that MariMed has developed spanning multiple states.